Thursday, November 19, 2026
  • Home
  • About us
  • Privacy policy
  • Advertise with us
  • Contact us
Fii News Logo
No Result
View All Result
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports
  • ASEANFastest Growing
Newsletter
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports
  • ASEANFastest Growing
Fiinews
No Result
View All Result
Home Health

Unilever to acquire GSK’s healthcare products

Fiinews by Fiinews
December 4, 2018
in Health, Investment, Manufacturing
Reading Time: 2 mins read
A A
0
0
SHARES
12
VIEWS
LinkedinShare on Twitter

HFD strategy for emerging markets

Anglo-Dutch group, Unilever, has signed an agreement to acquire the Health Food Drinks portfolio (GSK HFD) of GlaxoSmithKline (GSK) in India, Bangladesh and 20 other predominantly Asian markets.

Unilever’s share of the total consideration is Euro3.3 billion, payable using a combination of cash, and shares in its listed Indian subsidiary, Hindustan Unilever Limited.

Pending regulatory and shareholders clearances, the transaction completion is expected in 12 months.

In 2018, the GSK HFD portfolio delivered total turnover of Euro550 million, primarily through the Horlicks and Boost brands. Almost 90% of the turnover is in India.

The transaction is aligned with Unilever’s stated strategy of increasing its presence in health-food categories and in high-growth emerging markets.

GSK HFD is the undisputed leader in the Health Food Drinks category in India, with iconic brands such as Horlicks and Boost, and a product portfolio supported by strong nutritional claims.

This portfolio has a long history in India with Horlicks having originally been introduced in the 1930s.

Horlicks products have been an everyday staple in South Asian households across generations. Over the last 15 years, the portfolio (and category) has grown at a double-digit rate.

Despite this, the category still remains under-penetrated in India. Unilever is well positioned to further develop the market given the extent of its reach and capabilities.

Nitin Paranjpe, President, Food & Refreshment, Unilever, said: “The acquisition is transformative for our Foods and Refreshment business allowing us to enter the Health Foods Drinks category, further strengthening our position in health and wellness.

“It is rare to be able to acquire brands with such leading market positions and fantastic consumer equity in one of the world’s most exciting and fast-growing markets.

“Improving the health and wellbeing of one billion people by 2020 is a key pillar in our Unilever Sustainable Living Plan. Horlicks and Boost will add to our stable of purpose driven brands that help consumers to get more out of their lives,” said Paranjpe.

Sanjiv Mehta, Chairman and CEO, Hindustan Unilever said: “With this strategic merger of Hindustan Unilever and GSK Consumer Healthcare India Limited, we will be expanding our portfolio through great brands into a new category catering to the nutritional needs of our consumers. I am confident that this merger will create significant shareholder value through both revenue and cost synergies.

“The turnover of our Foods & Refreshments business will now exceed Rs. 100 billion and we will become one of the largest F&R businesses in the country. We look forward to welcoming new brands and great talent into the Unilever and HUL family, once the transaction is complete.”

The merger includes the totality of operations within GSK CH India, including a consignment selling contract to distribute GSK’s Over-the-Counter and Oral Health products in India.

Acquisition of 82% stake in GSK Bangladesh:

Unilever will acquire, for cash, 82% of the shares of the publicly listed GSK Bangladesh Limited at an equity value of BDT16 billion(Euro169 millio), implying an EV/EBITDA multiple of c.15x.

Acquisition of certain other commercial operations and assets outside India:

Unilever will also acquire the commercial operations in 20 other predominantly Asian markets and the intellectual property rights for a total consideration of Euro470 million in cash. fiinews.com

Tags: Hindustan Unilever LtdUnilever
ShareTweetShare

Related Posts

HZL and Vedanta combined logo
Investment

Invest: HZL to double production to 2 mtpa

by Fiinews
November 19, 2026
0
15

CEO Prakash works on HZL 2.0 for India’s industrial development. Hindustan Zinc Limited (HZL - NSE:HINDZINC), the world’s largest integrated...

Vikram Solar
Manufacturing

Manufacture: TN facility to produce from Dec 2026

by Fiinews
November 16, 2026
0
18

Vikram to set up 9 GW of backward-integrated ingot and wafer capacity Kolkata-headquartered Vikram Solar Limited says its 9-GW N-type...

ISNT

Manufacture: Minister wants strengthened NDT ecosystem

November 17, 2026
17
Singapore Exchange

Invest: UTI Nifty listed in Singapore

November 14, 2026
20
NITI Aayog

Manufacture: PLI successful, says NITI Aayog

November 14, 2026
17
Zetsol

Manufacture: 22 bids received for ACC facilities

November 14, 2026
22
SBI YONO

Recent News

  • Project: MoD inks contract with Israel Aerospace Industries
  • Market: Urban consumers prefer electric mobility
  • Invest: HZL to double production to 2 mtpa
  • Market: Rootstock expands in India through Conserve
  • Market: HGS-Rackspace to grow in high-value GCCs

Pages

  • About US
  • ADVERTISE ON FIINEWS.COM
  • CONTACT US
  • EVENTS
  • FII-NEWS.COM PDF ARCHIVE
  • Home
  • News
  • PRIVACY POLICY
  • About
  • Advertise
  • Careers
  • Contact us

© 2026 FIINEWS - Design and developed by 7clicksmedia.

No Result
View All Result
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports
  • ASEAN

© 2026 FIINEWS - Design and developed by 7clicksmedia.